// App-Quantinova.ai

2105-293 : CLOPIDOGREL WITH AND WITHOUT PROTON PUMP INHIBITOR USE: A PARIS REGISTRY ANALYSIS

Researchers

Presenter

  • Sameer Bansilal

Principal Investigators

  • Usman Baber

  • George Dangas

  • Ioannis Iakovou

  • Ron Waksman

  • Philippe Steg

  • Giora Weisz

  • Melissa Aquino

  • Timothy Henry

  • Annapoorna Kini

  • Thomas Stuckey

  • David Cohen

  • Peter Berger

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Clopidogrel bisulfate

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved